Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

2-(4-(diethylamino) phenyl)-6-methyl-2H-benzo[d][1,2,3] triazol-5-amine

EU orphan designation number: EU/3/06/385
Active ingredient: 2-(4-(diethylamino) phenyl)-6-methyl-2H-benzo[d][1,2,3] triazol-5-amine
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: Vastox plc.
91 Milton Park, Abingdon, Oxfordshire, OX14 4RY, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2006 Orphan designation EMEA/OD/025/06 (2006)3437 of 25/07/2006
19/12/2008 Removal of orphan designation from Community Register